Keywords: Bristol-Myers Squibb, Chief finanical officer
Bristol-Myers Squibb names interim CFO as Huet chooses to go back to Europe
Article | 15 December 2009
US drug major Bristol-Myers Squibb has appointed company veteran Charles Bancroft as acting chief financial officer effective January 1, 2010 and announced ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
